University of Hamburg

Plastics Hall of Fame Announces Class of 2024 Inductees

Retrieved on: 
Thursday, February 1, 2024
University of Hamburg, Polymer, PPI, Dow Chemical Company, Orange County Convention Center, Titanium, Regeneration, University of Connecticut, Plastic, Cellophane, Shin-Etsu Chemical, Chemistry, Nobel Prize, Dow, University of Massachusetts Lowell, Commercialization, Pioneer, University

MINNEAPOLIS, Feb. 1, 2024 /PRNewswire-PRWeb/ -- Seventeen new members will be honored at the Class of 2024 induction ceremony on Sunday, May 5, 2024, in the Orange County Convention Center, Orlando, FL.

Key Points: 
  • Seventeen new Plastic Hall of Fame members will be honored at the Class of 2024 induction ceremony on Sunday, May 5, 2024, in the Orange County Convention Center, Orlando, FL.
  • MINNEAPOLIS, Feb. 1, 2024 /PRNewswire-PRWeb/ -- Seventeen new members will be honored at the Class of 2024 induction ceremony on Sunday, May 5, 2024, in the Orange County Convention Center, Orlando, FL.
  • Established in 1972, the Plastics Hall of Fame has grown to 236 members representing nine countries, which include five Nobel Prize winners in chemistry.
  • The Plastics Hall of Fame recognizes the outstanding achievements of such individuals and inspires those entering the industry around the world.

BZAM completes acquisition of Final Bell's Canadian Operation; Adding Final Bell Holdings International as Strategic Shareholder

Retrieved on: 
Monday, January 8, 2024
Cannabis, FBC, Acquisition, International, Transaction, Chairperson, MBA, News, University of Hamburg, Security (finance)

VANCOUVER, BC, Jan. 8, 2024 /PRNewswire/ - BZAM Ltd. ("BZAM") (CSE: BZAM) (US-OTC: BZAMF) is pleased to announce that, further to the news release dated December 6, 2023, it has completed the acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. ("FBC") from Final Bell Holdings International Ltd. ("FBHI") (the "Transaction").

Key Points: 
  • VANCOUVER, BC, Jan. 8, 2024 /PRNewswire/ - BZAM Ltd. ("BZAM") (CSE: BZAM) (US-OTC: BZAMF) is pleased to announce that, further to the news release dated December 6, 2023, it has completed the acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. ("FBC") from Final Bell Holdings International Ltd. ("FBHI") (the "Transaction").
  • The Transaction combines BZAM's cultivation, production, and sales infrastructure with the portfolio of international brands that Final Bell is bringing to market in Canada.
  • "It has been our vision to be Canada's favourite source for cannabis.
  • His experience has been leveraged by companies worldwide to raise approximately a quarter of a billion dollars in financing.

EQS-News: Hawesko Holding SE: Hendrik Schneider becomes new Chief Financial Officer

Retrieved on: 
Saturday, December 30, 2023
HAW, CFO, Politics, Wine, Frankfurt Stock Exchange, Otto GmbH, Otto, Supervisory board, University of Hamburg, Management

Hamburg, November 21, 2023: The wine trading group Hawesko Holding SE (HAW, HAWG.DE, DE0006042708) announces that the company's Supervisory Board has appointed Hendrik Schneider as Chief Financial Officer (CFO).

Key Points: 
  • Hamburg, November 21, 2023: The wine trading group Hawesko Holding SE (HAW, HAWG.DE, DE0006042708) announces that the company's Supervisory Board has appointed Hendrik Schneider as Chief Financial Officer (CFO).
  • After holding management positions in the Controlling/Finance division of the Otto Group, Hamburg, he is currently Chief Financial Officer at Hermes Germany GmbH.
  • Hendrik Schneider on his new role: "I am delighted to soon be part of the largest premium wine trading group.
  • The shares in Hawesko Holding SE are listed on the Hanseatic Stock Exchange, Hamburg, and in the Prime Standard segment of the Frankfurt Stock Exchange.

Axogen Announces Transition of Finance Team Leadership

Retrieved on: 
Wednesday, December 6, 2023
AstraZeneca, CFO, Business administration, Nerve, LL.B, Tel Aviv University, Growth, KPMG, Employment, University of Hamburg, Management

A senior finance executive with more than 20 years of experience primarily in the life sciences industry, he replaces Peter Mariani, who will depart Axogen following a brief transition period.

Key Points: 
  • A senior finance executive with more than 20 years of experience primarily in the life sciences industry, he replaces Peter Mariani, who will depart Axogen following a brief transition period.
  • “We determined with the Board of Directors that a change to our finance team leadership was in Axogen’s best interests as our strategic focus evolves,” said Karen Zaderej, the Company’s Chairman, President and Chief Executive Officer.
  • “Pete was integral in helping us build Axogen and our platform for product manufacturing and sales growth.
  • Mr. Naor has diverse finance and operations leadership experience with public and private pharma, life sciences, and medtech companies worldwide.

University of Hamburg Awarded the 2023 WRDS-SSRN Innovation Prize for Commitment to Academic Research

Retrieved on: 
Wednesday, November 29, 2023
Software, Professional Services, Business, Data Management, Technology, Other Education, Continuing, University, Education, Data Analytics, Other Professional Services, Finance, Social science, Research, Policy, Multimedia, Faculty, Victoria Kent, SSRN, WRDS, AACSB, University of Hamburg, Economics, Management, Nursing

The Innovation Award series elevates the visibility of impact-focused research and the rising business schools that conduct it.

Key Points: 
  • The Innovation Award series elevates the visibility of impact-focused research and the rising business schools that conduct it.
  • View the full release here: https://www.businesswire.com/news/home/20231129500715/en/
    Victoria Kent announces University of Hamburg - Faculty of Business, Economics, and Social Sciences as winner of the 2023 WRDS-SSRN Innovation Award.
  • Dr. Cord Jakobeit, Dean, University of Hamburg – Faculty of Business, Economics and Social Sciences accepted the award via video .
  • “I am delighted to offer my congratulations to University of Hamburg – Faculty of Business, Economics and Social Sciences,” said Robert Zarazowski, Managing Director, WRDS.

Durin Technologies, Inc., Appoints CEO

Retrieved on: 
Wednesday, November 22, 2023
Health, Neurology, Mental Health, Medical Devices, Alzheimer's disease, Thermo Fisher Scientific, Cell biology, U.S.–Canada Team Tournament (Go), Roche, Multimedia, GE HealthCare, Marketing, University, Neurodegenerative disease, Growth, Doctor of Philosophy, University of Hamburg, HIV disease progression rates, Medical device, Management, Dwarves in Middle-earth

Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, today announced the appointment of Dr. Mert Sahin as Chief Executive Officer.

Key Points: 
  • Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, today announced the appointment of Dr. Mert Sahin as Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20231122887173/en/
    Mert Sahin, PhD Joins Durin Technologies as CEO.
  • (Photo: Business Wire)
    Dr. Sahin is a highly accomplished business executive with an impressive track record of success in the life sciences sector.
  • He brings to Durin more than 20 years of experience in life sciences, pharmaceuticals, and medical devices, where he has demonstrated expertise in formulating and executing strategic go-to-market plans resulting in exceptional growth.

EQS-News: Aurubis AG: Environmentally friendly metals: Aurubis concludes ammonia tests and plans to intensify cooperation with ADNOC

Retrieved on: 
Thursday, December 14, 2023
Partnership, Zinc, Hydrogen, Plant, Social Democratic Party, Carbon, Applied science, Aurubis, Selenium, Lead, ADNOC, Sustainability, Copper, CO2, Nitrogen, MDAX, Multimeter, Metal, News, Living lab, Climate, Letter, Tin, Nickel, Natural Resources, University of Hamburg, Frankfurt Stock Exchange, Electricity, Environment, Natural gas, Security (finance), Industrial gas, Renewable energy, Economics, Ammonia

Following testing, Aurubis is pursuing strategic cooperation in the area of hydrogen with ADNOC, the supplier of the low-carbon ammonia for the test series in Aurubis’ production.

Key Points: 
  • Following testing, Aurubis is pursuing strategic cooperation in the area of hydrogen with ADNOC, the supplier of the low-carbon ammonia for the test series in Aurubis’ production.
  • The ammonia used in Aurubis’ testing arrived in Hamburg as part of a joint hydrogen project between the United Arab Emirates and Germany.
  • During the test series, which ran for several months, Aurubis successfully used ammonia as an energy source in the copper wire rod production facility.
  • Aurubis has around 7,100 employees, production sites in Europe and the US, and an extensive distribution network around the world.

TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS

Retrieved on: 
Thursday, November 9, 2023
University of Los Andes (Colombia), IPO, Biogen, Therapy, Tajikistan State University of Law, Business, & Politics, Tree, Doctor of Philosophy, MBA, Engineering, HEC Paris, Central Executive Committee (PAP), Politics, Growth, Trinity College, Medicine, Paris, Executive Committee, Business, Senior, University of Hamburg, Ethicon, University, Trinity College Dublin, Sanofi, International communication, La Jolla Institute for Immunology, Immunology, Management, Bayer, Merck

BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics, a global biotechnology company advancing a pipeline of cell therapies based on a disruptive proprietary technology platform, today announced the appointment of three new members to the Executive Team.

Key Points: 
  • "Since our inception in 2018, TreeFrog has made great strides, and I am proud of the progress the teams have made in our therapeutic programs, technology and partnerships.
  • We are part of the revolution in medicine, pioneering therapeutics and technology in cell therapy.
  • Reinforcing the Executive Committee team is crucial for the next phase in our future growth," Frederic Desdouits, PhD, CEO of TreeFrog Therapeutics.
  • For further information on the Executive Committee, visit www.treefrog.fr

TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS

Retrieved on: 
Thursday, November 9, 2023
University of Los Andes (Colombia), IPO, Biogen, Therapy, Tajikistan State University of Law, Business, & Politics, Tree, Doctor of Philosophy, MBA, Engineering, HEC Paris, Central Executive Committee (PAP), Politics, Growth, Trinity College, Medicine, Paris, Executive Committee, Business, Senior, University of Hamburg, Ethicon, University, Trinity College Dublin, Sanofi, International communication, La Jolla Institute for Immunology, Immunology, Management, Bayer, Merck

BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics, a global biotechnology company advancing a pipeline of cell therapies based on a disruptive proprietary technology platform, today announced the appointment of three new members to the Executive Team.

Key Points: 
  • "Since our inception in 2018, TreeFrog has made great strides, and I am proud of the progress the teams have made in our therapeutic programs, technology and partnerships.
  • We are part of the revolution in medicine, pioneering therapeutics and technology in cell therapy.
  • Reinforcing the Executive Committee team is crucial for the next phase in our future growth," Frederic Desdouits, PhD, CEO of TreeFrog Therapeutics.
  • For further information on the Executive Committee, visit www.treefrog.fr

Being told where their blood ends up encourages donors to give again – new research

Retrieved on: 
Monday, October 2, 2023
Blood, American Red Cross, Organization, World Blood Donor Day, German Red Cross, Research, University, Red Cross, University of Hamburg, Austrian Red Cross, American, Population, Time, International Red Cross and Red Crescent Movement, Medical device, Pharmaceutical industry

Working with the Austrian Red Cross, we looked at whether nearly 75,000 people who had donated in the prior two years would return to give blood.

Key Points: 
  • Working with the Austrian Red Cross, we looked at whether nearly 75,000 people who had donated in the prior two years would return to give blood.
  • They were either thanked for their previous donation, thanked and told how their blood was used, or thanked and told how their next donation would be used.
  • If giving donors more information about how their blood was used boosts blood donations, it can save lives.
  • We plan to discover whether and how organizations that collect donated blood should tell donors when that happens with their blood.